NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1

K Wang1, D-L Zhang2, B Long3

  • 1Center for Developmental Cardiology, Institute for Translational Medicine, College of Medicine, Qingdao University, Qingdao, China.

Cell Death & Disease
|December 4, 2015
PubMed

Insights

Abnormal mitochondrial fission contributes to heart disease. This study identifies the NFAT4/miR-324-5p/Mtfr1 axis regulating mitochondrial fission and cardiomyocyte death, offering potential therapeutic targets for cardiac conditions.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Dynamics
  • Molecular Cardiology

Background:

  • Abnormal mitochondrial fission is implicated in cardiac diseases like myocardial infarction and heart failure.
  • The specific molecular regulators of mitochondrial networks in the heart are not fully understood.

Purpose of the Study:

  • To identify key molecular components regulating mitochondrial morphology and cardiomyocyte apoptosis in the heart.
  • To elucidate the signaling axis involving NFAT4, miR-324-5p, and Mtfr1 in cardiac pathogenesis.

Main Methods:

  • Investigated the role of NFAT4, miR-324-5p, and mitochondrial fission regulator 1 (Mtfr1) in regulating mitochondrial morphology.
  • Utilized knockdown experiments to assess the impact of Mtfr1 and NFAT4 on mitochondrial fission, apoptosis, and myocardial infarction.
  • Determined the regulatory relationship between miR-324-5p and Mtfr1, and between NFAT4 and miR-324-5p.

Main Results:

  • Knocking down Mtfr1 reduced mitochondrial fission, apoptosis, and myocardial infarction.
  • miR-324-5p directly targets Mtfr1, attenuating mitochondrial fission and cardiomyocyte apoptosis.
  • NFAT4 was found to inhibit miR-324-5p expression, and its knockdown protected against mitochondrial fission and cardiomyocyte death.

Conclusions:

  • The NFAT4/miR-324-5p/Mtfr1 signaling axis is a critical regulator of mitochondrial fission and cardiomyocyte apoptosis.
  • This axis represents a potential therapeutic target for treating cardiac diseases such as myocardial infarction and heart failure.